HIV-1 restriction by SERINC5

被引:6
作者
Cano-Ortiz, Lucia [1 ,2 ]
Luedde, Tom [1 ]
Muenk, Carsten [1 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Fac Med, Clin Gastroenterol Hepatol & Infectiol, Bldg 23-12-U1-82,Moorenstr 5, D-40225 Dusseldorf, Germany
[2] Univ Fed Rio Grande, Inst Ciencias Basicas Saude, Dept Microbiol, Lab Virol, Porto Alegre, RS, Brazil
关键词
SERINC5; Nef; HIV-1; Restriction factors; HUMAN-IMMUNODEFICIENCY-VIRUS; PRIMATE LENTIVIRUSES; INFECTIVITY FACTOR; GLYCOSYLATED-GAG; PROTEIN FAMILY; PORE FORMATION; NEF; REPLICATION; ANTAGONISM; FUSION;
D O I
10.1007/s00430-022-00732-x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serine incorporator 5 (SERINC5 or SER5) is a multipass transmembrane protein with ill-defined cellular activities. SER5 was recently described as a human immunodeficiency virus 1 (HIV-1) restriction factor capable of inhibiting HIV-1 that does not express its accessory protein Nef (Delta Nef). SER5 incorporated into the viral membrane impairs the entry of HIV-1 by disrupting the fusion between the viral and the plasma membrane after envelope receptor interaction induced the first steps of the fusion process. The mechanisms of how SER5 prevents membrane fusion are not fully understood and viral envelope proteins were identified that escape the SER5-mediated restriction. Primate lentiviruses, such as HIV-1 and simian immunodeficiency viruses (SIVs), use their accessory protein Nef to downregulate SER5 from the plasma membrane by inducing an endocytic pathway. In addition to being directly antiviral, recent data suggest that SER5 is an important adapter protein in innate signaling pathways leading to the induction of inflammatory cytokines. This review discusses the current knowledge about HIV-1 restriction by SER5.
引用
收藏
页码:133 / 140
页数:8
相关论文
共 50 条
  • [41] HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity
    Naicker, Delon
    Sonela, Nelson
    Jin, Steven W.
    Mulaudzi, Takalani
    Ojwach, Doty
    Reddy, Tarylee
    Brockman, Mark A.
    Brumme, Zabrina L.
    Ndung'u, Thumbi
    Mann, Jaclyn K.
    RETROVIROLOGY, 2023, 20 (01)
  • [42] The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles
    Trautz, Birthe
    Wiedemann, Hannah
    Luechtenborg, Christian
    Pierini, Virginia
    Kranich, Jan
    Glass, Barbel
    Kreausslich, Hans-Georg
    Brocker, Thomas
    Pizzato, Massimo
    Ruggieri, Alessia
    Bruegger, Britta
    Fackler, Oliver T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (33) : 13702 - 13713
  • [43] Relative resistance of patient-derived envelope sequences to SERINC5-mediated restriction of HIV-1 infectivity
    Nkuwi, Emmanuel
    Judicate, George P.
    Tan, Toong Seng
    Barabona, Godfrey
    Toyoda, Mako
    Sunguya, Bruno
    Kamori, Doreen
    Ueno, Takamasa
    JOURNAL OF VIROLOGY, 2023, 97 (10)
  • [44] Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5
    Jin, Steven W.
    Mwimanzi, Francis M.
    Mann, Jaclyn K.
    Bwana, Mwebesa Bosco
    Lee, Guinevere Q.
    Brumme, Chanson J.
    Hunt, Peter W.
    Martin, Jeff N.
    Bangsberg, David R.
    Ndung'u, Thumbi
    Brumme, Zabrina L.
    Brockman, Mark A.
    PLOS PATHOGENS, 2020, 16 (09)
  • [45] An Amino Acid Polymorphism within the HIV-1 Nef Dileucine Motif Functionally Uncouples Cell Surface CD4 and SERINC5 Downregulation
    Mumby, Mitchell J.
    Johnson, Aaron L.
    Trothen, Steven M.
    Edgar, Cassandra R.
    Gibson, Richard
    Stathopulos, Peter B.
    Arts, Eric J.
    Dikeakos, Jimmy D.
    JOURNAL OF VIROLOGY, 2021, 95 (16)
  • [46] A bipartite structural organization defines the SERINC family of HIV-1 restriction factors
    Pye, Valerie E.
    Rosa, Annachiara
    Bertelli, Cinzia
    Struwe, Weston B.
    Maslen, Sarah L.
    Corey, Robin
    Liko, Idlir
    Hassall, Mark
    Mattiuzzo, Giada
    Ballandras-Colas, Allison
    Nans, Andrea
    Takeuchi, Yasuhiro
    Stansfeld, Phillip J.
    Skehel, J. Mark
    Robinson, Carol, V
    Pizzato, Massimo
    Cherepanov, Peter
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2020, 27 (01) : 78 - +
  • [47] Murine Leukemia Virus Glycosylated Gag Reduces Murine SERINC5 Protein Expression at Steady-State Levels via the Endosome/Lysosome Pathway to Counteract SERINC5 Antiretroviral Activity
    Li, Sunan
    Ahmad, Iqbal
    Shi, Jing
    Wang, Bin
    Yu, Changqing
    Zhang, Lixin
    Zheng, Yong-Hui
    JOURNAL OF VIROLOGY, 2019, 93 (02)
  • [48] S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3
    Chande, Ajit
    Cuccurullo, Emilia Cristiana
    Rosa, Annachiara
    Ziglio, Serena
    Carpenter, Susan
    Pizzato, Massimo
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (46) : 13197 - 13202
  • [49] Flow Cytometry Analysis of HIV-1 Env Conformations at the Surface of Infected Cells and Virions: Role of Nef, CD4, and SERINC5
    Staropoli, Isabelle
    Dufloo, Jeremy
    Ducher, Anais
    Commere, Pierre-Henri
    Sartori-Rupp, Anna
    Novault, Sophie
    Bruel, Timothee
    Lorin, Valerie
    Mouquet, Hugo
    Schwartz, Olivier
    Casartelli, Nicoletta
    JOURNAL OF VIROLOGY, 2020, 94 (06)
  • [50] Feline Leukemia Virus-B Envelope Together With its GlycoGag and Human Immunodeficiency Virus-1 Nef Mediate Resistance to Feline SERINC5
    Cano-Ortiz, Lucia
    Gu, Qinyong
    de Sousa-Pereira, Patricia
    Zhang, Zeli
    Chiapella, Catherina
    Twizerimana, Augustin Penda
    Lin, Chaohui
    Franco, Ana Claudia
    VandeWoude, Sue
    Luedde, Tom
    Baldauf, Hanna-Mari
    Muenk, Carsten
    JOURNAL OF MOLECULAR BIOLOGY, 2022, 434 (06)